REMSleep Holdings, Inc. (RMSL)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.0001 (-1.64%)
Oct 10, 2025, 3:57 PM EDT
REMSleep Holdings Market Cap
REMSleep Holdings has a market cap or net worth of $4.88 million as of October 10, 2025. Its market cap has decreased by -67.69% in one year.
Market Cap
4.88M
Enterprise Value
4.61M
Revenue
36.53K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 8, 2010, REMSleep Holdings's market cap has decreased from 45.32M to 4.88M, a decrease of -89.24%. That is a compound annual growth rate of -13.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 4.88M | -61.44% |
| Dec 31, 2024 | 12.65M | -44.18% |
| Dec 29, 2023 | 22.66M | 24.00% |
| Dec 30, 2022 | 18.27M | 16.26% |
| Dec 31, 2021 | 15.71M | 1,001.06% |
| Dec 31, 2020 | 1.43M | 36.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 314.22M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |